Song Y. Park

Dermatology

3100 Northup Way
Bellevue, WA 98004

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Risk of selected immune-mediated inflammatory diseases after solid organ transplantation in a Korean nationwide cohort.

Risk of selected immune-mediated inflammatory diseases after solid organ transplantation in a Korean nationwide cohort.

Journal: JAAD international

Published: July 11, 2026

ctDNA or Merkel Virus Antibodies for Surveillance of Merkel Cell Carcinoma Recurrence.

ctDNA or Merkel Virus Antibodies for Surveillance of Merkel Cell Carcinoma Recurrence.

Journal: JAMA dermatology

Published: July 08, 2026

Real-world outcomes of talimogene laherparepvec as salvage therapy for advanced melanoma.

Real-world outcomes of talimogene laherparepvec as salvage therapy for advanced melanoma.

Journal: Journal for immunotherapy of cancer

Published: December 08, 2025

An Update to Ethnoracial Gaps in Global Hidradenitis Suppurativa Clinical Trials.

An Update to Ethnoracial Gaps in Global Hidradenitis Suppurativa Clinical Trials.

Journal: Skin appendage disorders

Published: November 29, 2025

Clinical benefit of adding radiation for immune checkpoint inhibitor-refractory Merkel cell carcinoma: A 27-patient analysis.

Clinical benefit of adding radiation for immune checkpoint inhibitor-refractory Merkel cell carcinoma: A 27-patient analysis.

Journal: The Journal of investigative dermatology

Published: October 16, 2025

Polyomavirus Antibodies for Merkel Cell Carcinoma Recurrence Detection.

Polyomavirus Antibodies for Merkel Cell Carcinoma Recurrence Detection.

Journal: JAMA dermatology

Published: September 10, 2025

Scalp Micropigmentation for Camouflage of Cicatricial Alopecia From Lichen Planopilaris.

Scalp Micropigmentation for Camouflage of Cicatricial Alopecia From Lichen Planopilaris.

Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Published: July 22, 2025

Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade.

Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade.

Journal: Journal for immunotherapy of cancer

Published: July 21, 2025

Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management.

Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management.

Journal: Journal of the American Academy of Dermatology

Published: June 30, 2025

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy.

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy.

Journal: Journal of the American Academy of Dermatology

Published: December 20, 2024

Postmarketing safety surveillance of adalimumab, secukinumab, and infliximab in hidradenitis suppurativa: an analysis of the FDA adverse events reporting system (FAERS) database.

Postmarketing safety surveillance of adalimumab, secukinumab, and infliximab in hidradenitis suppurativa: an analysis of the FDA adverse events reporting system (FAERS) database.

Journal: Journal of the American Academy of Dermatology

Published: December 18, 2024

Immunotherapy response in immunosuppressed patients with Merkel cell carcinoma: analysis of 183 patients.

Immunotherapy response in immunosuppressed patients with Merkel cell carcinoma: analysis of 183 patients.

Journal: BMJ oncology

Published: October 30, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026